-
Perospirone (SM-9018 free base) in Translational Research
2026-08-24
Perospirone is more than a receptor pharmacology tool. Its combined 5-HT2A, D2, and 5-HT1A activity, alongside newly reported Kv1.5 inhibition in coronary arterial smooth muscle cells, creates a strategic opportunity to connect schizophrenia research with cardiovascular safety and mechanism studies.
-
miR-18a, ALOXE3, and Ferroptosis in Glioblastoma
2026-08-23
Yang and colleagues identify a miR-18a/ALOXE3 axis that connects lipid metabolism with ferroptosis resistance and migration in glioblastoma. The study combines molecular, cellular, metabolite, and orthotopic mouse experiments, providing a mechanistic framework for investigating how altered oxylipin signaling contributes to GBM progression.
-
Reelin-SFK Signaling in Ketamine Action
2026-08-22
The reference study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway for ketamine-induced hippocampal synaptic plasticity and behavioral effects. Its genetic and pharmacological experiments suggest that impaired baseline NMDA receptor function, rather than failure of ketamine to alter Reelin signaling acutely, may contribute to antidepressant nonresponse.
-
Z-VAD-FMK Workflows for Apoptosis Research
2026-08-22
Build more decisive apoptosis experiments with Z-VAD-FMK, from caspase activity measurement and rescue assays to mechanistic studies of oncolytic virus therapy. This guide combines practical dosing logic, controls, storage advice, and a breast cancer use case drawn from recent rMeV-Hu191 research.
-
Temafloxacin Workflows for Antibacterial Research
2026-08-21
Temafloxacin enables dose-ranging, intracellular, and respiratory infection workflows that connect DNA replication inhibition with practical bacterial susceptibility readouts. Its broad pathogen coverage and defined DMSO handling make it useful for comparative assays spanning Gram-positive, Gram-negative, atypical, and mycobacterial models.
-
Imatinib (STI571): A Context-Aware Assay Guide
2026-08-20
Imatinib (STI571) is a precise tool for dissecting Abl, PDGF receptor, and c-Kit signaling. This guide connects kinase inhibition assays with new evidence on hypoxia-driven erythroid differentiation to improve experimental interpretation in cancer biology research.
-
Mitochondrial Membrane Potential Assay with JC-1
2026-08-20
Learn how the JC-1 Mitochondrial Membrane Potential Assay Kit converts ΔΨm changes into a practical, ratiometric readout. This guide connects assay design with mechanistic interpretation in apoptosis and immunomodulatory cancer research.
-
GANT61: Selective GLI Inhibitor Guide
2026-08-19
GANT61 is a GLI inhibitor that suppresses GLI1- and GLI2-dependent transcription downstream of canonical Hedgehog signaling. Product and peer-reviewed evidence support its use in cancer research, while immune-checkpoint applications remain mechanistic research questions rather than established GANT61 effects.
-
Monomethyl auristatin E: ADC Workflow Guide
2026-08-19
Monomethyl auristatin E (MMAE) is a powerful antibody-drug conjugate payload for studying targeted cytotoxicity, microtubule disruption, and resistance across cancer models. This guide translates its mechanism into practical assay design, dose planning, model selection, and troubleshooting while clarifying how it complements, rather than replaces, differentiation-focused research.
-
LEE011 succinate: CDK Inhibitor Workflow Guide
2026-08-18
Build reproducible CDK4/6 inhibition experiments with LEE011 succinate, from stock preparation through cell-cycle and proliferation readouts. This guide also shows how a longitudinal biomarker strategy from prostate cancer research can sharpen endpoint selection without overstating cross-disease evidence.
-
In Situ TIL Therapy Through Localized mRNA Delivery
2026-08-18
This ACS Nano study introduces an in situ tumor-infiltrating lymphocyte therapy that uses lipid nanoparticles to deliver mRNA encoding a membrane-anchored anti-CD3 single-chain variable fragment. Local engineering of tumor-associated macrophages and tumor cells promoted polyclonal CD8+ T-cell expansion and tumor engagement in mouse models, with enhanced activity when combined with anti-PD-1 treatment.
-
MLN4924 HCl Salt for NAE Pathway Studies
2026-08-17
Use MLN4924 HCl salt to connect NAE activity with cullin-RING ligase function, protein turnover, cell-cycle phenotypes, and inflammatory cell death. This practical guide translates a viral RIPK3-degradation study into controlled biochemical and cellular workflows while separating evidence-backed conclusions from assay-development recommendations.
-
(R,S)-Anatabine: Aβ Research Workflow
2026-08-17
Use (R,S)-Anatabine to connect APP processing, BACE-1 regulation, soluble Aβ peptide reduction, and NF-κB signaling in a staged Alzheimer’s disease workflow. This guide emphasizes orthogonal readouts, solvent control, model selection, and troubleshooting for translational neurodegeneration research.
-
Monomethyl Auristatin E (MMAE): Mechanism & Use
2026-08-16
Monomethyl auristatin E (MMAE) is a potent tubulin-directed cytotoxic payload used in antibody-drug conjugates. Its subnanomolar cell-based potency, defined solvent profile, and dependence on antibody-linker design make it valuable for cancer therapy research but unsuitable for interpretation as a free-drug clinical treatment.
-
miR-18a, ALOXE3, and Ferroptosis in Glioblastoma
2026-08-15
The reference study identifies a miR-18a–ALOXE3 axis that promotes glioblastoma by weakening p53-SLC7A11-dependent ferroptosis and increasing 12-HETE-driven migration. Its combination of molecular perturbation, lipid signaling analysis, and orthotopic modeling provides a useful framework for connecting lipid metabolism with GBM progression and for designing mechanistic follow-up studies.